Invest Ophthalmol Vis Sci 55(12):81739 Thaller M et al (2023) The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes
Multiple studies have observed that people with metabolic challenges tend to have significantly lower levels of Akkermansia in their gut microbiome,* and the landmark human clinical trial on pasteurized MucT a randomized, double-blind, placebo-controlled study demonstrated that supplementation improved insulin sensitivity, reduced insulinemia, and lowered plasma total cholesterol compared to placebo over three months.* The MucT strain is also the only Akkermansia to receive EFSA (European Food Safety Authority) novel food approval, based on its extensive safety and efficacy data.* Convenience Both products are one capsule daily
In the animal model [105], lutein and zeaxanthin were found to modulate anti-inflammatory cytokine (IL-10) in the liver and jejunum as well as proinflammatory cytokines (IL-1, IL-6, and IFN-) in the liver, duodenum, jejunum, and ileum
These disorders include neuromyelitis optica (NMO, also known as unilateral optic neuritis), isolated or recurrent transverse myelitis, longitudinally extensive transverse myelitis or isolated brain lesions with or without detectable anti AQP4-IgG autoantibody